Khalid Zarug
Endocrinology, Diabetes & Metabolism · Evansville, INNPI 1629381447
Payments from drug & device makers
Across 452 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$795
- Dexcom, Inc.$635
- Amgen$617
- Abbott$609
- Medtronic$569
- plus $3K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 69 | $1,092 |
| Lilly USA, LLC | 44 | $795 |
| Dexcom, Inc. | 33 | $635 |
| Amgen | 34 | $617 |
| Abbott | 42 | $609 |
| Medtronic(2 entities) | 42 | $569 |
| Insulet Corporation | 31 | $548 |
| Boehringer Ingelheim | 24 | $342 |
| AbbVie | 19 | $296 |
| Corcept Therapeutics | 15 | $272 |
| Tandem Diabetes Care, Inc. | 12 | $195 |
| Recordati_rare_diseases_inc. | 9 | $187 |
| Mannkind Corporation | 10 | $165 |
| Antares Pharma, Inc. | 11 | $153 |
| AstraZeneca(2 entities) | 7 | $136 |
| Sanofi-aventis U.S. LLC | 8 | $122 |
| Novartis | 8 | $121 |
| BETA Bionics, Inc. | 3 | $94 |
| Bayer | 5 | $83 |
| Merck | 1 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Averitas Pharma Inc. | 2 | $55 |
| Ultragenyx Pharmaceutical Inc. | 2 | $41 |
| Radius Health, Inc. | 2 | $36 |
| Nevro Corp. | 2 | $33 |
| Sequel Med Tech, LLC | 1 | $32 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Ascensia Diabetes Care US Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $16 |
| Lifescan, Inc. | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$7,570 in reported general payments places this provider in the 70th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.
See all endocrinology, diabetes & metabolism providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Evansville
- Mary TadrosEvansville$6K
- Carmella Evans-MolinaIndianapolis$6.3M
- Isaiah PittmanTerre Haute$1.5M
- Ernest AsamoahIndianapolis$959K
- Sana MeahMunster$829K
- James MaloneIndianapolis$822K
- Erica KretchmanRichmond$636K
- Emily VeenemanSeymour$583K
- Cary MariashIndianapolis$435K
- Marian KirkmanIndianapolis$371K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.